F.D.A. Approves Heart Drug Entresto Said to Cut Death Risk by 20%

The drug, Entresto, could eventually achieve more than $5 billion in annual sales, said Novartis, which developed it.











from NYT > Health http://ift.tt/1NMMab8
via health&fitness